RT Journal Article
SR Electronic
T1 Remote Intensive Parent-Implemented Intervention for Young Children on the Autism Spectrum During Covid-19: The Experience of Parents and Therapists
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.30.22270029
DO 10.1101/2022.01.30.22270029
A1 Wood de Wilde, Hilary
A1 Kojovic, Nada
A1 Robertson, Céline
A1 Karr, Catherine
A1 Akman, Leyla
A1 Caccia, Florence
A1 Costes, Astrid
A1 Etienne, Morgane
A1 Franchini, Martina
A1 Gentaz, Edouard
A1 Schaer, Marie
YR 2022
UL http://medrxiv.org/content/early/2022/03/22/2022.01.30.22270029.abstract
AB In response to a Covid-19 period of home-confinement, autism early intervention programs in Geneva, Switzerland, converted their in-person services to a telehealth format. Forty-five families received daily videoconferencing sessions of primarily parent-implemented intervention. Questionnaires were completed at three time points. Child progress was monitored using the Early Start Denver Model Curriculum Checklist. Parents maintained high levels of participation and satisfaction, regardless of socio-economic or cultural background, with the majority reporting an improvement in their use of intervention techniques. Child progress followed a pattern of continued significant improvement across most developmental domains. Findings suggest that a more frequent dosage of parent-implemented intervention than typically studied is not only feasible, but appreciated by caregivers, especially when delivered via the time-saving videoconferencing format.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by grants from the Swiss National Science Foundation (#190084 and 51NF40 - 185897) and by the Fondation Pole Autisme (https://www.pole-autisme.ch). The funders were not involved in this study and had no role other than to provide financial support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The relevant Ethics Committee regulating all work performed at the Faculty of Medicine of the Geneva University is the Commission Cantonale d'Ethique de la Recherche sur l’être humain Regional Research Ethics Committee Geneva Switzerland. The Commission Cantonale d'Ethique de la Recherche sur l’être humain Regional Research Ethics Committee Geneva Switzerland(CCER) approved the current project (PB201601880) on April 20 2020. The methods used in the present study were performed in full accordance with the relevant guidelines and regulations of Geneva University.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study are available upon a reasonable request to the 1st author of the study.